4.6 Article

Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells

Journal

GENES
Volume 10, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/genes10120964

Keywords

PVT1 exon 9; prostate cancer; malignant transformation; castration resistance

Funding

  1. National Cancer Institute [U54 CA221704]

Ask authors/readers for more resources

Prostate cancer (PCa) is the most common non-cutaneous cancer and second leading cause of cancer-related death for men in the United States. The nonprotein coding gene locus plasmacytoma variant translocation 1 (PVT1) is located at 8q24 and is dysregulated in different cancers. PVT1 gives rise to several alternatively spliced transcripts and microRNAs. There are at least twelve exons of PVT1, which make separate transcripts, and likely have different functions. Here, we demonstrate that PVT1 exon 9 is significantly overexpressed in PCa tissues in comparison to normal prostate tissues. Both transient and stable overexpression of PVT1 exon 9 significantly induced greater prostate epithelial cell migration, as well as increased proliferation and corresponding proliferating cell nuclear antigen (PCNA) expression. Notably, implantation into mice of a non-tumorigenic prostate epithelial cell line stably overexpressing PVT1 exon 9 resulted in the formation of malignant tumors. Furthermore, PVT1 exon 9 overexpression significantly induced castration resistance. Consequently, PVT1 exon 9 expression is important for PCa initiation and progression, and holds promise as a therapeutic target in PCa.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Oncogenic Role of PVT1 and Therapeutic Implications

Onayemi Titilayo Onagoruwa, Gargi Pal, Chika Ochu, Olorunseun O. Ogunwobi

FRONTIERS IN ONCOLOGY (2020)

Article Genetics & Heredity

Population Differentiation at the PVT1 Gene Locus: Implications for Prostate Cancer

Gargi Pal, Lia Di, Akintunde Orunmuyi, E. Oluwabunmi Olapade-Olaopa, Weigang Qiu, Olorunseun O. Ogunwobi

G3-GENES GENOMES GENETICS (2020)

Article Oncology

Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin-Low Triple Negative Breast Cancer Cells

Fayola Levine, Olorunseun O. Ogunwobi

Summary: The study reveals that PVT1 exon 9 plays a role in regulating claudin 4 expression and migration, particularly in claudin-low triple negative breast cancer, suggesting potential clinical implications.

CANCERS (2021)

Article Oncology

Prostac: A New Composite Score With Potential Predictive Value in Prostate Cancer

E. O. Asante-Asamani, Gargi Pal, Leslie Liu, Olorunseun O. Ogunwobi

Summary: Prostate cancer is the most commonly diagnosed solid organ cancer in men globally, and current diagnosis methods have limitations. The creation of a new composite score, Prostac, based on recently discovered PCa biomarkers, shows promise for improving PCa diagnosis accuracy.

FRONTIERS IN ONCOLOGY (2021)

Article Medicine, General & Internal

Pattern of Prostate Cancer Recurrence Assessed by 68Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy

Ismaheel O. Lawal, Thabo Lengana, Gbenga O. Popoola, Akintunde T. Orunmuyi, Mankgopo M. Kgatle, Kgomotso M. G. Mokoala, Mike M. Sathekge

Summary: Ga-68-PSMA-11 PET/CT plays a crucial role in guiding salvage therapy for detecting prostate cancer recurrence, demonstrating a high lesion detection rate for biochemical recurrence in patients previously treated with primary local therapy. Risk of extra-pelvic recurrence increases with rising PSA levels.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

A Bone Scan Is Valuable for Primary Staging of Newly Diagnosed Prostate Cancer in a Low-Resource Setting (Nigeria)

Akintunde T. Orunmuyi, Sikiru A. Adebayo, Olayinka S. Ilesanmi, Augustine O. Takure, E. Oluwabunmi Olapade-Olaopa

Summary: This study analyzed the bone scan results of newly diagnosed prostate cancer patients in Nigeria and found a positive correlation between bone metastases and PSA levels and Gleason scores. No patients with PSA levels < 20 ng/mL and Gleason scores < 7 had bone metastases. The findings of this study are consistent with global reports.

NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Editorial Material Oncology

Racism Does Not Cause Prostate Cancer, It Causes Prostate Cancer Death

Andrew J. Vickers, Brandon Mahal, Olorunseun O. Ogunwobi

JOURNAL OF CLINICAL ONCOLOGY (2023)

Review Clinical Neurology

The performance of machine learning approaches for attenuation correction of PET in neuroimaging: A meta-analysis

Confidence Raymond, Michael T. Jurkiewicz, Akintunde Orunmuyi, Linshan Liu, Michael Oluwaseun Dada, Claes N. Ladefoged, Jarmo Teuho, Udunna C. Anazodo

Summary: This systematic review provides a consensus on the clinical feasibility of machine learning methods for brain PET attenuation correction. The performance of ML-AC was compared to clinical standards. The results suggest that ML-AC has acceptable performance for clinical PET imaging but further research is needed to assess its robustness and clinical implementation.

JOURNAL OF NEURORADIOLOGY (2023)

Article Public, Environmental & Occupational Health

Effective Recruitment Strategies Utilized to Examine Dietary Practices of Blacks in New York City in the Midst of the COVID-19 Pandemic

Cicely K. Johnson, May May Leung, Grace X. X. Ma, Olorunseun O. Ogunwobi

Summary: This study investigated the participation rate of self-identified Black individuals in New York City in a study on the relationship between dietary practices and colorectal cancer screening behavior. The results showed that recruiting Black participants was not challenging, but individuals in Caribbean neighborhoods expressed mistrust and declined to participate, suggesting the need for further work to address this recruitment challenge.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2023)

Letter Oncology

Reply to M. Roach et al and KH Stopsack et al

Andrew J. Vickers, Brandon Mahal, Olorunseun O. Ogunwobi

JOURNAL OF CLINICAL ONCOLOGY (2023)

Meeting Abstract Oncology

Investigating the clinical relevance in prostate cancer of the serum biomarkers PVT1 exons 4A, 4B and 9 across risk levels and ethnicity/race

Fayola Levine, Emmanuel Asante-Asamani, Gargi Pal, Michael Liss, Olorunseun Ogunwobi

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Meeting Abstract Oncology

Educating the next generation of cancer researchers: Evaluation of a cancer research partnership research training program

Lin Zhu, Gargi Pal, Taylor Kazaoka, Rubia Shahbaz, Marsha Zibalese-Crawford, Sarah-Jane Dodd, Carolyn Y. Fang, Yin Tan, Grace X. Ma, Olorunseun O. Ogunwobi

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Medicine, General & Internal

Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study

Akinfemi Akingboye, Fahad Mahmood, Nabeel Amiruddin, Michael Reay, Peter Nightingale, Olorunseun O. Ogunwobi

Summary: Patients with active cancer have a threefold increase in risk of hospitalisation with COVID-19, and higher age, urea, and CRP levels are associated with increased mortality. Machine learning algorithm (MLA) shows potential in predicting outcomes of COVID-19 infection in cancer patients.

BMJ OPEN (2021)

Meeting Abstract Oncology

Computation of a user-friendly composite score from three prostate cancer biomarkers.

Gargi Pal, Emmanuel Asante-Asamani, Leslie Liu, Olorunseun O. Ogunwobi

CANCER RESEARCH (2021)

Meeting Abstract Oncology

PVT1 exons 4A and 4B overexpressed in prostate cancer in black males regulate prostate epithelial cell proliferation and migration

Gargi Pal, Olorunseun Ogunwobi

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

No Data Available